Research Topic

Recent 3D Tumor Models for Testing Immune-Mediated Therapies

About this Research Topic

Infections and cancer are severe causes of death in the world and, although numerous therapeutic options exist, they are not always effective. Failure is due to several reasons including limitations of current pre-clinical in vitro and in vivo animal models, which are far from being reproducible and predictive of response to therapies. Therefore, there is the emerging need to develop novel and reliable in vitro 3D tumor models to study the efficacy of potential therapeutics, including vaccination and strategies aimed to enhance anti-tumor immune responses. This will allow standardized investigations and assays with a reproducible outcome.

In the last decades, different biomaterials have been proposed and developed for resembling the special features of lymphoid tissues or tumor microenvironment, including the proper stiffness and degradability. Among them, hydrogels, porous scaffolds and bioprinted materials have been utilized to hold cancer cells together with cells of the tumor microenvironment to recreate cancer lesions in many different cancer hystotypes such as breast, ovarian, prostate, melanoma and neuroblastoma. Tumor cell viability, proliferation, migration, immune-phenotype and sensitivity to anticancer drugs and immunotherapies have to be consolidated in order to proof the reliability of these novel 3D in vitro models.

We invite investigators to contribute with Original Research articles as well as Reviews, Minireviews or General Commentaries describing recent findings in the field of 3D models to test different therapies against cancer or immune-mediated diseases. Thus, potential topics include, but are not limited to:

• 3D cancer models for testing current and novel anticancer immunotherapies, including chimeric antigen receptor (CAR) T and natural killer (NK) cell-based immunotherapies.
• 3D models for testing current and novel vaccination strategies.
• Tumor organoids and targeted immune-therapies.
• 3D cancer models for testing current and novel anticancer drugs.

Topic Editor Dr. Scaglione is employed at the startup React4life. The other Topic Editors declare no competing interests with regards to the Research Topic theme


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Infections and cancer are severe causes of death in the world and, although numerous therapeutic options exist, they are not always effective. Failure is due to several reasons including limitations of current pre-clinical in vitro and in vivo animal models, which are far from being reproducible and predictive of response to therapies. Therefore, there is the emerging need to develop novel and reliable in vitro 3D tumor models to study the efficacy of potential therapeutics, including vaccination and strategies aimed to enhance anti-tumor immune responses. This will allow standardized investigations and assays with a reproducible outcome.

In the last decades, different biomaterials have been proposed and developed for resembling the special features of lymphoid tissues or tumor microenvironment, including the proper stiffness and degradability. Among them, hydrogels, porous scaffolds and bioprinted materials have been utilized to hold cancer cells together with cells of the tumor microenvironment to recreate cancer lesions in many different cancer hystotypes such as breast, ovarian, prostate, melanoma and neuroblastoma. Tumor cell viability, proliferation, migration, immune-phenotype and sensitivity to anticancer drugs and immunotherapies have to be consolidated in order to proof the reliability of these novel 3D in vitro models.

We invite investigators to contribute with Original Research articles as well as Reviews, Minireviews or General Commentaries describing recent findings in the field of 3D models to test different therapies against cancer or immune-mediated diseases. Thus, potential topics include, but are not limited to:

• 3D cancer models for testing current and novel anticancer immunotherapies, including chimeric antigen receptor (CAR) T and natural killer (NK) cell-based immunotherapies.
• 3D models for testing current and novel vaccination strategies.
• Tumor organoids and targeted immune-therapies.
• 3D cancer models for testing current and novel anticancer drugs.

Topic Editor Dr. Scaglione is employed at the startup React4life. The other Topic Editors declare no competing interests with regards to the Research Topic theme


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

20 July 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

20 July 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..